Differential Potency of Factors Affecting Innovation Performance in Manufacturing and Services Firms in Australia

1996 ◽  
Vol 13 (1) ◽  
pp. 35-52 ◽  
Author(s):  
Kwaku Atuahene-Gima
2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Leila Eslami Eshlaghi ◽  
Abbas Khamseh

Background: The pharmaceutical industry has a significant impact on the promotion of health and safety indicators in society. In this knowledge-based industry, the development of companies in complex environments is a function of innovative research, investment, and government regulation to maintain and survive. Given the technical knowledge and specific supportive laws (e.g., patents), being active in such an industry is one of the important criteria in developing countries. Therefore, the generic plan was implemented in Iran with the prospect of taking practical steps toward achieving drug self-sufficiency and acquiring the rank of manufactured pharmaceutical raw materials and branded drugs. Objectives: This study, therefore, aimed to investigate factors affecting innovation performance in establishing a generic plan in the pharmaceutical industry of developing countries. Methods: The statistical population in this descriptive survey consisted of PhD experts involved in the Iranian pharmaceutical industry. To this end, 42 standard questionnaires were distributed based on the conceptual model of the research. Next, the effects of the research variables were analyzed using partial least squares (PLS) structural equations. Results: According to the results, research and development (R&D), product innovation, process innovation, and organization size significantly positively affected innovation performance. In comparison, knowledge management did not substantially affect innovation performance in the Iranian pharmaceutical industry. Conclusions: Due to the introspective developmental approach and the lack of effective communication, a major failure of the generic plan is witnessed within the pharmaceutical industry.


2021 ◽  
Vol 13 (8) ◽  
pp. 4122
Author(s):  
Eungdo Kim ◽  
InGyu Lee ◽  
Hongbum Kim ◽  
Kwangsoo Shin

Due to the high risk in development process, the bio-pharmaceutical industry has transformed itself into an open innovation framework in order to overcome economic risk. This study examines the relationship between outbound open innovation and financial performance in bio-pharmaceutical industry. Specifically, this study extends knowledge-based view to link the open innovation performance and licensor’s sustainability. In order to provide empirical evidence, this study uses econometric methodology with several databases including bio-pharmaceutical firms. The analysis shows firm’s desorptive capabilities have a significant effect on financial performance, confirming the application of knowledge capacity framework. The result of the study can suggest the way how the licensors can maintain the sustainability of competitiveness in bio-pharmaceutical industry.


2014 ◽  
Vol 30 (1) ◽  
pp. 7-10

Purpose – To examine the way that China's cultural traditions affect the country's approach to innovation management and evaluate the impact of the philosophy contained in the ancient I Ching text on effectiveness in translating research spending into patent applications. Design/methodology/approach – Compares innovation performance between countries with and without an awareness of the I Ching philosophy as part of their cultural tradition. Presents an econometric analysis of the relationship between research expenditures, proportion of population engaged in research and relative levels of patent applications in nine countries. Findings – Ask people about China today and the first thing they are likely to talk about is economic growth and the sheer volume of goods that the country manufactures and sends to Europe and America. It is unlikely though, that they will mention creativity and innovation. And yet, China's total number of patent applications rose tenfold between 2000 and 2007, from almost 20,000 to around 200,000 – only just behind Japan and the USA. This is a country that is changing fast, but it still only has ten years of experience of global competition – a key driver of innovation for many companies. It is worth asking whether exposure to western management techniques is as significant as China's long history and distinctive culture. How can Chinese entrepreneurs most effectively develop innovative organizations? Practical implications – Highlights both China's modest relative performance in innovation to date and the speed at which the country's patent applications have grown in recent years. Originality/value – Raises questions on the cultural factors affecting innovation performance for further qualitative and quantitative investigation.


2014 ◽  
Vol 521 ◽  
pp. 801-805
Author(s):  
Qiang Shao ◽  
You Jun Li ◽  
Jin Wang

Based on the theory of collaborative innovation and factors affecting enterprise technological innovation, combined with the actual situation of the petroleum enterprises, the performance evaluation model for petroleum enterprises collaborative technological innovation is built by using structural equations, enterprise data of sample enterprises is collected by using questionnaire. With empirical analysis for collaborative technological innovation performance of sample enterprises, factors affecting petroleum enterprise collaborative technological innovation are identified. It will provide the basis for making out measures to enhance petroleum enterprise collaborative technological innovation performance.


Sign in / Sign up

Export Citation Format

Share Document